Literature DB >> 22201863

Peripheral cholesterol, metabolic disorders and Alzheimer's disease.

Maria Dolores Ledesma1, Carlos Gerardo Dotti.   

Abstract

Strong correlations have been made between high levels of blood cholesterol and the risk to suffer Alzheimer's disease (AD). The question arises on how a peripheral event contributes to a disease that so severely affects the integrity and function of the Central Nervous System. Hypercholesterolemia has been also associated to peripheral metabolic disorders like diabetes, obesity or atherosclerosis that, in turn, predispose to AD. Here we review data, which point to alterations in blood cholesterol levels as a link between these metabolic disorders and AD. We describe and discuss common, cholesterol-related, molecular mechanisms and strategies to fight these conditions that, altogether, constitute a major cause of death in our societies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201863     DOI: 10.2741/e368

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  14 in total

Review 1.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-23       Impact factor: 4.191

Review 3.  Membrane properties that shape the evolution of membrane enzymes.

Authors:  Charles R Sanders; James M Hutchison
Journal:  Curr Opin Struct Biol       Date:  2018-03-27       Impact factor: 6.809

4.  Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice.

Authors:  Gonzalo Acero; Miryam Nava Catorce; Ricardo González-Mendoza; Marco Antonio Meraz-Rodríguez; Luis Fernando Hernández-Zimbron; Roberto González-Salinas; Goar Gevorkian
Journal:  Inflammopharmacology       Date:  2017-05-19       Impact factor: 4.473

Review 5.  Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease.

Authors:  Maria Laura Giuffrida; Flora Tomasello; Filippo Caraci; Santina Chiechio; Ferdinando Nicoletti; Agata Copani
Journal:  Mol Neurobiol       Date:  2012-08-12       Impact factor: 5.590

Review 6.  Cholesterol in brain disease: sometimes determinant and frequently implicated.

Authors:  Mauricio G Martín; Frank Pfrieger; Carlos G Dotti
Journal:  EMBO Rep       Date:  2014-09-15       Impact factor: 8.807

7.  Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis.

Authors:  Y K Adlakha; S Khanna; R Singh; V P Singh; A Agrawal; N Saini
Journal:  Cell Death Dis       Date:  2013-08-29       Impact factor: 8.469

8.  Cholesterol homeostasis: a key to prevent or slow down neurodegeneration.

Authors:  Laura Anchisi; Sandra Dessì; Alessandra Pani; Antonella Mandas
Journal:  Front Physiol       Date:  2013-01-04       Impact factor: 4.566

Review 9.  LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals.

Authors:  Miryam Nava Catorce; Goar Gevorkian
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 10.  Neuroprotective effects of statins against amyloid β-induced neurotoxicity.

Authors:  Hsin-Hua Li; Chih-Li Lin; Chien-Ning Huang
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.